Top 5 biopharma trends: The long-awaited biopharma revolution in China has arrived — don’t lose out
Several years ago I had seen enough biotech news coming out of China to decide that we were seeing the early stages of a major trend taking shape. This year, that trend has taken root and flowered in bigger ways than I had imagined. And it’s happening just as Big Pharma is winding down some major R&D efforts that played a big role in the biotech surge we’re seeing today.
Premium subscription required
Unlock this article along with other benefits by subscribing to one of our paid plans.